Tongkat Ali Capsule
Natural health product licensed in Canada
- Licence holder
- Beijing Norzer Bioltechnology Co., Ltd
- NPN or DIN-HM
- 80090514
- Status
- Active licence
- Licence date
- 8 February 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Eurycoma longifolia Source : Racine Extract : Matériel brut sec Extraction ratio : 200:1 Dry plant equivalent : 10 g | 50 mg | Not calculated |
Non-medicinal ingredients
Amidon de maïs modifié, Hypromellose, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Tongkat Ali helps promote testosterone production in men.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Some people may experience hypersensitivity/allergy, diarrhea, insomnia, anxiety, or headaches, in which case, discontinue use. Consult a health care practitioner prior to use if you are taking antidepressant medications, blood thinners or digoxin. Consult a health care practitioner prior to use if you have diabetes or are following a low-protein diet. Consult a health care practitioner prior to use if you have benign prostate hypertrophy and/or prostate cancer. Consult a health care practitioner prior to use if you suffer from any psychological disorder and/or condition such as frequent anxiety or depression. Consult a health care practitioner prior to use if you have been diagnosed with hypoactive sexual disorder, sexual dysfunction or erectile dysfunction. Consult a health care practitioner prior to use if you are taking propranolol.
Source
Official Health Canada record, licence 80090514
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.